Sucampo, Takeda obtain expanded approval for Amitiza

04/23/2013 | CNBC

The FDA has granted Sucampo Pharmaceuticals and Takeda Pharmaceuticals expanded approval for their Amitiza drug to treat constipation from opioids used for chronic pain. Forty percent or more of patients who use opioids for chronic pain not associated with cancer experience constipation, the companies said.

View Full Article in:

CNBC

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN